It was thus expected that blockade of both the Ang II-dependent pathway (by aliskiren) and the (P)RR-mediated, Ang II-independent pathway (by HRP) would provide better protection against diabetes-induced retinal pathophysiology. This evidence concerns the gene AGT and diabetes mellitus.